On Friday, FibroBiologics Inc (NASDAQ: FBLG) opened lower -5.81% from the last session, before settling in for the closing price of $0.86. Price fluctuations for FBLG have ranged from $0.76 to $13.59 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Company’s average yearly earnings per share was noted -28.68% at the time writing. With a float of $29.68 million, this company’s outstanding shares have now reached $37.74 million.
Considering the fact that the conglomerate employs 13 people, you should pay attention to its efficiency factor. In terms of profitability, gross margin is 0.0%, operating margin of 0.0%, and the pretax margin is 0.0%.
FibroBiologics Inc (FBLG) Breakdown of a Key Holders of the stock
A key investor’s attitude towards the stock of the Biotechnology industry is another important factor to consider. The insider ownership of FibroBiologics Inc is 22.43%, while institutional ownership is 16.93%. The most recent insider transaction that took place on Aug 12 ’24, was worth 16,269. In this transaction Chief Executive Officer of this company bought 8,500 shares at a rate of $1.91, taking the stock ownership to the 6,056,647 shares. Before that another transaction happened on Aug 12 ’24, when Company’s Chief Scientific Officer bought 10,000 for $1.90, making the entire transaction worth $19,000. This insider now owns 11,250 shares in total.
FibroBiologics Inc (FBLG) Recent Fiscal highlights
According to the Wall Street analysts, stocks earnings will be around -28.68% per share during the next fiscal year.
FibroBiologics Inc (NASDAQ: FBLG) Trading Performance Indicators
Check out the current performance indicators for FibroBiologics Inc (FBLG). In the past quarter, the stock posted a quick ratio of 1.14.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.21, a number that is poised to hit -0.12 in the next quarter and is forecasted to reach -0.47 in one year’s time.
Technical Analysis of FibroBiologics Inc (FBLG)
Compared to the last year’s volume of 0.26 million, its volume of 0.12 million showed lagged in the last five days. As of the previous 9 days, the stock’s Stochastic %D was 19.37%. Additionally, its Average True Range was 0.11.
During the past 100 days, FibroBiologics Inc’s (FBLG) raw stochastic average was set at 2.92%, which indicates a significant decrease from 5.88% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 110.71% in the past 14 days, which was higher than the 110.18% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $0.9875, while its 200-day Moving Average is $1.9153. Nevertheless, the first resistance level for the watch stands at $0.8575 in the near term. At $0.9049, the stock is likely to face the second major resistance level. The third major resistance level sits at $0.9347. If the price goes on to break the first support level at $0.7803, it is likely to go to the next support level at $0.7505. Now, if the price goes above the second support level, the third support stands at $0.7031.
FibroBiologics Inc (NASDAQ: FBLG) Key Stats
There are currently 38,263K shares outstanding in the company with a market cap of 30.99 million. Presently, the company’s annual sales total 0 K according to its annual income of -11,160 K. Last quarter, the company’s sales amounted to 0 K and its income totaled -4,970 K.
